Age-related differences in reporting of drug-associated liver injury: data-mining of WHO Safety Report Database.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Regulatory toxicology and pharmacology : RTP

• Publication date

  2014-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.yrtph.2014.09.007PMID 25236535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methylprednisolone-induced hepatotoxicity: experiences from global adverse drug reaction surveillance

  2014cited by this paper
• Associations of Gender and Age with the Reporting of Drug‐Induced Hepatic Failure: Data from the VigiBase™

  2013cited by this paper
• An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.

  2013cited by this paper
• High lipophilicity and high daily dose of oral medications are associated with significant risk for drug‐induced liver injury

  2013cited by this paper
• Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management.

  2013cited by this paper
• Implication of hepatic transporters (MDR1 and MRP2) in inflammation‐associated idiosyncratic drug‐induced hepatotoxicity investigated by microvolume cytometry

  2013cited by this paper
• A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

  2013cited by this paper
• In Vitro Inhibition of the Bile Salt Export Pump Correlates with Risk of Cholestatic Drug-Induced Liver Injury in Humans

  2012cited by this paper
• Recent global endeavors in the detection and prevention of drug-induced liver injury.

  2012cited by this paper
• Central role of mitochondria in drug-induced liver injury

  2012cited by this paper
• Pathogenesis of propylthiouracil-related hepatotoxicity in children: present concepts

  2012cited by this paper
• In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugs.

  2012cited by this paper
• Genetic association studies in drug-induced liver injury

  2012cited by this paper
• Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.

  2012cited by this paper
• Characteristics of Idiosyncratic Drug-induced Liver Injury in Children: Results From the DILIN Prospective Study

  2011cited by this paper
• Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-γ inhibition.

  2011cited by this paper
• Drug uptake transporters in antiretroviral therapy.

  2011cited by this paper
• Liver Regeneration and Aging: A Current Perspective

  2011cited by this paper
• Telomere dysfunction, autoimmunity and aging.

  2011cited by this paper
• Pharmacogenetics of drug‐induced liver injury

  2010cited by this paper
• Drug-induced hepatic injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase.

  2010cited by this paper
• Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transport.

  2010cited by this paper
• High-Content Screening for Compounds That Affect mtDNA-Encoded Protein Levels in Eukaryotic Cells

  2010cited by this paper
• Drugs Associated with Hepatotoxicity and their Reporting Frequency of Liver Adverse Events in VigiBase™

  2010cited by this paper
• Biliary efflux transporters involved in the clearance of rosuvastatin in sandwich culture of primary rat hepatocytes.

  2010cited by this paper
• Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events

  2010cited by this paper
• Drug Induced Hypersensitivity and the HLA Complex

  2010cited by this paper
• Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children.

  2010cited by this paper
• MicroRNA and aging: a novel modulator in regulating the aging network.

  2010cited by this paper
• The Role of Epigenetics in Aging and Autoimmunity

  2010cited by this paper
• Outcome of acute liver failure in the elderly

  2009cited by this paper
• Outcome of liver transplantation for drug‐induced acute liver failure in the United States: Analysis of the united network for organ sharing database

  2009cited by this paper
• Impact of OATP transporters on pharmacokinetics

  2009cited by this paper
• Pharmacokinetics and drug metabolism in the elderly

  2009cited by this paper
• Phenotypic characterization of idiosyncratic drug‐induced liver injury: The influence of age and sex

  2009cited by this paper
• Mitochondrial biogenesis and healthy aging.

  2008cited by this paper
• VigiBase, the WHO Global ICSR Database System: Basic Facts

  2008cited by this paper
• Drug-related hepatotoxicity and acute liver failure.

  2008cited by this paper
• Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase γ (POLG1)

  2008cited by this paper
• Relationship between daily dose of oral medications and idiosyncratic drug‐induced liver injury: Search for signals

  2008cited by this paper
• Strategies to reduce late-stage drug attrition due to mitochondrial toxicity

  2007cited by this paper
• Serious adverse drug events reported to the Food and Drug Administration, 1998-2005.

  2007cited by this paper
• Use of Complementary and Alternative Therapies in Community-Dwelling Older Adults

  2007cited by this paper
• Comparative Performance of Two Quantitative Safety Signalling Methods

  2006cited by this paper
• Erythromycin breath test results in elderly, very elderly, and frail elderly persons

  2006cited by this paper
• Hepatobiliary transporters and drug‐induced cholestasis

  2006cited by this paper
• Roxithromycin induced hypersensitivity pneumonitis.

  2006cited by this paper
• Mitochondrial oxidative stress and permeability transition in isoniazid and rifampicin induced liver injury in mice.

  2006cited by this paper
• Acute liver failure in children.

  2006cited by this paper
• Adverse reactions to first-line antituberculosis drugs

  2006cited by this paper
• MULTIPLE MECHANISMS ARE INVOLVED IN THE BILIARY EXCRETION OF ACETAMINOPHEN SULFATE IN THE RAT: ROLE OF MRP2 AND BCRP1

  2005cited by this paper
• Perspectives on the Use of Data Mining in Pharmacovigilance

  2005cited by this paper
• Pharmacokinetic dosage guidelines for elderly subjects

  2005cited by this paper
• Acute and clinically relevant drug-induced liver injury: a population based case-control study.

  2004cited by this paper
• Toxicity of low dose azathioprine and 6-mercaptopurine in rat hepatocytes. Roles of xanthine oxidase and mitochondrial injury.

  2004cited by this paper
• Incidence and preventability of adverse drug events among older persons in the ambulatory setting.

  2003cited by this paper
• Allergy to dogfish

  2003cited by this paper
• Developmental pharmacology--drug disposition, action, and therapy in infants and children.

  2003cited by this paper
• Mechanisms of NSAID-Induced Hepatotoxicity

  2002cited by this paper
• Inhibition of transport across the hepatocyte canalicular membrane by the antibiotic fusidate.

  2002cited by this paper
• Incidence of drug‐induced hepatic injuries: A French population‐based study

  2002cited by this paper
• Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

  2002cited by this paper
• Clinical Pharmacokinetics of Nimesulide

  1998cited by this paper
• Nimesulide-induced acute hepatitis: evidence from six cases.

  1998cited by this paper
• Four cases of severe hepatotoxicity associated with pemoline: possible autoimmune pathogenesis.

  1998cited by this paper
• Pemoline hepatotoxicity in children.

  1998cited by this paper
• Investigation into the age-dependence of the pharmacokinetics of cyproterone acetate in healthy male volunteers

  1997cited by this paper
• Hepatic cytochrome P-4503A (CYP3A) activity in the elderly.

  1992cited by this paper
• Effect of age and gender on the activity of human hepatic CYP3A.

  1992cited by this paper
• Effect of normal aging on the activity of human hepatic cytochrome P450IIE1.

  1990cited by this paper
• Delayed type hypersensitivity to fusidic acid in patients with chronic dermatitis.

  1990cited by this paper
• Antibiotic therapy in aging patients.

  1987cited by this paper
• Roxithromycin: a pharmacokinetic review of a macrolide.

  1987cited by this paper
• Drug therapy in the elderly.

  1981cited by this paper
• Endocrine and metabolic diseases. Treatment of thyroid disease: I.

  1976cited by this paper
• [Absorption, distribution and excretion of 14C-josamycin and 14C-josamycin propionate in rats (author's transl)].

  1975cited by this paper
• Chlorpromazine photoallergy. Coexistence of immediate and delayed type.

  1975cited by this paper
• Biliary excretion of 35 S-labelled propylthiouracil, methimazole and carbimazole in untreated and pentobarbitone pretreated rats.

  1972cited by this paper

• Influence of patient age and sex on drug-induced liver injury caused by antiseizure medications: a disproportionality analysis of VigiBase

  2025cites this paper
• Research Progress on the Etiology of Cholestatic Liver Disease in School-Age Children

  2025cites this paper
• Epidemiology and Risk Determinants of Drug‐Induced Liver Injury: Current Knowledge and Future Research Needs

  2024cites this paper
• Prediction of adverse drug reactions using demographic and non-clinical drug characteristics in FAERS data

  2024cites this paper
• Insights from pharmacovigilance and pharmacodynamics on cardiovascular safety signals of NSAIDs

  2024cites this paper
• Liver injury associated with endothelin receptor antagonists: a pharmacovigilance study based on FDA adverse event reporting system data

  2024cites this paper
• Age-related differences in drug-induced liver injury: a retrospective single-center study from a large liver disease specialty hospital in China, 2002–2022

  2024influential citation
• Clinical and biochemical characteristics, and outcome in 33 patients with ceftriaxone-induced liver injury

  2024cites this paper
• A brief overview of drug-induced liver damage

  2024cites this paper
• Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative

  2024cites this paper
• Systematic Review and Meta-Analysis: Comparing Hepatocellular and Cholestatic Patterns of Drug Induced Liver Injury

  2023cites this paper
• Clinical profiles and risk predictors of drug-induced liver injury from pirfenidone and nintedanib used to treat idiopathic pulmonary fibrosis: a real-world analysis of a tertiary Chinese hospital cohort combined with FAERS data mining

  2023cites this paper
• Research Progress on Drug-Induced Liver Injury in the Elderly

  2023cites this paper
• Autoimmunity associates with severity of illness in elderly patients with drug-induced liver injury

  2023cites this paper
• Frequency of drug-induced liver injury in children receiving anti-staphylococcal penicillins

  2022cites this paper
• Evaluation of Drug-Induced Liver Injury in Hospitalized Patients with SARS-CoV-2 Infection

  2022cites this paper
• A pharmacovigilance study of the association between tetracyclines and hepatotoxicity based on Food and Drug Administration adverse event reporting system data

  2022cites this paper
• Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice

  2021cites this paper
• Potential Effects of Dietary Isoflavones on Drug-Induced Liver Injury

  2021cites this paper
• Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly

  2021influential citation
• ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.

  2021cites this paper
• An Approach to Drug-Induced Liver Injury from the Geriatric Perspective

  2021cites this paper
• Drug Induced Liver Injury in Geriatric Patients Detected by a Two-Hospital Prospective Pharmacovigilance Program: A Comprehensive Analysis Using the Roussel Uclaf Causality Assessment Method

  2021cites this paper
• Drug induced liver injury: an update

  2020cites this paper
• Understanding Idiosyncratic Toxicity: Lessons Learned from Drug-Induced Liver Injury.

  2020cites this paper
• Drug-induced liver injury in older people.

  2020cites this paper
• Clinical features and prognosis of drug-induced liver injury under hypoxia conditions

  2020cites this paper
• Clinical Characteristics and Outcome of Drug‐Induced Liver Injury in the Older Patients: From the Young‐Old to the Oldest‐Old

  2020cites this paper
• EASL Clinical Practice Guidelines: Drug-induced liver injury.

  2019cites this paper
• The evolution of ideas about medicinal liver damage

  2019cites this paper
• Drug-induced liver injury

  2019cites this paper
• Tools for causality assessment in drug-induced liver disease

  2019cites this paper
• EASL Clinical Practice Guidelines: Drug-induced liver injury

  2019cites this paper
• Drug-Induced Liver Injury in Older Adults

  2019cites this paper
• Interplay of gender, age and drug properties on reporting frequency of drug‐induced liver injury

  2018cites this paper
• Nonacetaminophen Drug-Induced Acute Liver Failure.

  2018cites this paper
• Host Risk Modifiers in Idiosyncratic Drug-Induced Liver Injury (DILI) and Its Interplay with Drug Properties

  2018cites this paper
• Oštećenje jetre ksenobioticima

  2018cites this paper
• Drug-induced liver injury: a safety review

  2018cites this paper
• Chinese Herbal Medicine Hepatotoxicity: The Evaluation and Recognization Based on Large-scale Evidence Database

  2018cites this paper
• Risk Factors of any skin cancer 1

  2018cites this paper
• Epidemiology and Genetic Risk Factors of Drug Hepatotoxicity.

  2017cites this paper
• Improving Prediction Accuracy of Disease Prediction using Hybrid Approach of KNN and Euclidean Distance

  2017cites this paper
• Drug-induced liver injury: Do we know everything?

  2017cites this paper
• Performance analysis of classification algorithms on early detection of liver disease

  2017cites this paper
• Comprehensive review of techniques used to detect skin lesion

  2017cites this paper
• Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays

  2017cites this paper
• Quercetin protection against ciprofloxacin induced liver damage in rats

  2016cites this paper
• An intelligent medical Replenishment System for managing the medical resources in the healthcare industry

  2016cites this paper
• Retrieval, visualization, and mining of large radiation dosage data

  2016cites this paper
• Drug-induced liver injury in children

  2015cites this paper
• Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk.

  2015cites this paper
• The Art and Science of Diagnosing and Managing Drug-induced Liver Injury in 2015 and Beyond.

  2015cites this paper
• A Survey and Compare the Performance of IBM SPSS Modeler and Rapid Miner Software for Predicting Liver Disease by Using Various Data Mining Algorithms

  2015cites this paper
• Drug-induced liver injury: Interactions between drug properties and host factors.

  2015cites this paper
• Idiosyncratic Drug-Induced Liver Injury: Mechanisms and Susceptibility Factors

  2014cites this paper